[Expert recommendation: treatment of nonambulatory patients with Duchenne muscular dystrophy].
Sign Up to like & getrecommendations! Published in 2020 at "Der Nervenarzt"
DOI: 10.1007/s00115-020-01019-3
Abstract: BACKGROUND Duchenne muscular dystrophy (DMD) is the most frequent genetic neuromuscular disease in childhood with loss of ambulation usually occurring around the age of 9-11 years. OBJECTIVE, MATERIAL AND METHODS Based on current guidelines and clinical… read more here.
Keywords: dmd patients; ambulation; treatment; disease ... See more keywords
Obesity and loss of ambulation are associated with lower extremity oedema in Duchenne muscular dystrophy
Sign Up to like & getrecommendations! Published in 2022 at "Cardiology in the Young"
DOI: 10.1017/s1047951122001342
Abstract: Abstract Patients with Duchenne muscular dystrophy have multiple risk factors for lower extremity oedema. This study sought to define the frequency and predictors of oedema. Patients aged 15 years and older were screened by patient… read more here.
Keywords: duchenne muscular; lower extremity; extremity oedema; oedema ... See more keywords
Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy.
Sign Up to like & getrecommendations! Published in 2022 at "Developmental medicine and child neurology"
DOI: 10.1111/dmcn.15176
Abstract: AIM To correlate the North Star Ambulatory Assessment (NSAA) and timed rise from floor (TRF) recorded at age of expected peak with age at loss of ambulation (LOA) in Duchenne muscular dystrophy (DMD). METHOD Male… read more here.
Keywords: loss ambulation; trf; duchenne muscular; years months ... See more keywords